SUMMARY
Macrophages adapt both phenotypically and functionally to the cytokine balance in host tissue microenvironments. Recent studies established that macrophages contribute an important yet poorly understood role in the development of infection-elicited oral bone loss. We hypothesized that macrophage adaptation to inflammatory signals encountered before pathogen interaction would significantly influence the subsequent immune response of these cells to the keystone oral pathobiont Porphyromonas gingivalis. Employing classically activated (M1) and alternatively activated (M2) murine bone-marrow-derived macrophage (BMDMø), we observed that immunologic activation of macrophages before P. gingivalis challenge dictated phenotype-specific changes in the expression of inflammation-associated molecules important to sensing and tuning host response to bacterial infection including Toll-like receptors 2 and 4, CD14, CD18 and CD11b (together comprising CR3), major histocompatibility complex class II, CD80, and CD86. M2 cells responded to P. gingivalis with higher expression of tumor necrosis factor-a, interleukin-6, monocyte chemoattractant protein-1, macrophage inflammatory protein-1a, regulated on activation normal T cell expressed and secreted, and KC than M1 cells. M1 BMDMø expressed higher levels of interleukin-10 to P. gingivalis than M2 BMDMø. Functionally, we observed that M2 BMDMø bound P. gingivalis more robustly than M1 BMDMø. These data describe an important contribution of macrophage skewing in the subsequent development of the cellular immune response to P. gingivalis.
INTRODUCTION
Periodontal diseases are chronic inflammatory diseases of the periodontium that in severe cases lead to destruction of the hard and soft tissues supporting the teeth, and bacteria-elicited inflammation serves as the nidus of this destructive host response. Porphyromonas gingivalis is an organism associated with chronic periodontitis in part through its ability to stimulate microbial dysbiosis in subgingival plaque, and locally modulate expression of host immune factors (Darveau et al., 2012; Hajishengallis et al., 2015 Hajishengallis et al., , 2016 . Individuals with periodontal disease present with a complex array of expressed inflammatory and anti-inflammatory mediators (Gemmell et al., 2001a; Seymour & Gemmell, 2001) , as well as a complex cellular infiltration with early neutrophilic responses followed by lymphocytes, dendritic cells, and monocytes/macrophages (Charon et al., 1981; Kinane, 2000; Pihlstrom et al., 2005; Schenkein, 2006) . This array of tissue-specific cues serves as the driver of cellular recruitment, and promotes the shifts in cell populations present in periodontal tissues. Lymphocytes contribute to P. gingivalis-elicited oral bone loss (Baker et al., 1994; Wang et al., 2014) ; however, recent studies point to a critical role for macrophages in the host response to, and pathogen-elicited oral bone loss by, P. gingivalis (Papadopoulos et al., 2013; Lam et al., 2014) .
Macrophages develop from a common myeloid progenitor cell that also gives rise to dendritic cells, polymorphonuclear leukocytes, and mast cells (Gordon & Taylor, 2005; Epelman et al., 2014) . In addition, tissue-resident macrophages arise from local progenitor cell populations seeded at sites early in ontogeny (Dey et al., 2014) . Macrophages perform a myriad of functions in the host, including phagocytic uptake of foreign material, innate immune sensing and antigen presentation to T cells, and secretion of inflammatory and anti-inflammatory mediators, as well as assisting with tissue homeostasis through clearance of necrotic and apoptotic cells (Geppert & Lipsky, 1989; Gordon, 2003; Sica & Mantovani, 2012) .
Upon tissue localization, macrophages respond to inflammatory, anti-inflammatory, and regulatory cues in the cellular microenvironment that further drive phenotypic change in these cells -a process of immunologic skewing termed polarization (Biswas & Mantovani, 2010) . In mice, two principal macrophage activation phenotypes have been characterized and are designated classically activated (M1), and alternatively activated (M2) cells (Mantovani et al., 2005) . These activation states represent the antitheses of a polarization continuum (Mosser & Edwards, 2008) . In vitro M1 cells develop in response to interferon-c (IFN-c) and lipopolysaccharide (LPS), or tumor necrosis factor-a (TNF-a) treatment (Cassetta et al., 2011) . M1 macrophages produce copious nitric oxide (Mulder et al., 2014) , and are associated with protection during infection (Mosser, 2003) . M2 macrophages were originally described based on the atypical activation observed in response to interleukin-4 (IL-4; Stein et al., 1992) ; however, M2 cells also arise from stimuli including IL-10, and immune complexes (Martinez & Gordon, 2014) . Broadly, M2 macrophages are associated with tissue homeostasis, resolution of inflammation, tissue repair, and chronic infections (Benoit et al., 2008; Sica & Mantovani, 2012; Snyder et al., 2016) .
Differing levels of key mediators of macrophage skewing including IFN-c and IL-4 are reported between healthy individuals and those with periodontitis (Navarrete et al., 2014) . Hence, although macrophages comprise 5-30% of cells identified in the cellular infiltrate of human periodontal disease lesions (Okada & Murakami, 1998) , little is known regarding how macrophage skewing contributes to periodontal disease, and more specifically in the downstream development of a macrophage immune response to periodontal-disease-associated bacteria. By modeling the effect of different inflammatory cues that drive macrophage activation before pathogen encounter, we report that skewed bone-marrow-derived macrophages (BMDMø) interact with, and respond to, live P. gingivalis challenge with unique signatures that may have important implications in the pathogenesis of periodontal disease.
METHODS

Mice, macrophage collection, and immunologic skewing
Male 6-to 10-week-old C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) were used as a source of BMDMø, and all animals were cared for and used in accordance with Boston University Institutional Animal Care and Use Committee approvals. Following sacrifice, BMDMø were generated from bone marrow cells as previously described (Shaik-Dasthagirisaheb et al., 2010) . After 7 days, BMDMø were collected (~95% pure by F4/80 + staining), placed into 12-well tissue culture plates and M1 BMDMø were generated by 3-day treatment with recombinant murine IFN-c (100 U ml
À1
; R&D Systems Minneapolis, MN) and ultrapure Escherichia coli 0111:B4 LPS (10 ng ml À1 ; Invivogen, San Diego, CA), while M2 BMDMø were generated by 3-day treatment with recombinant murine IL-4 (20 U ml
; R&D Systems). Reference BMDMø (M0) were maintained in differentiation medium. Following skewing, cells were washed and cultured in antibiotic-free complete cell culture medium. BMDMø skewing was confirmed by flow cytometry targeting major histocompatibility complex class II (MHCII) and CD86 surface protein expression, quantitative reverse transcription polymerase chain reaction (RT-qPCR) measuring nos2 (M1 marker) and arg1 (M2 marker) gene expression, Griess assay measuring nitrite production (Shaik-Dasthagirisaheb et al., 2010) , and enzyme-linked immunosorbent assay measuring TNF-a and IL-6.
RNA harvest and RT-qPCR
Levels of nos2 and arg1 gene expression were determined by RT-qPCR using Taqman murine primer sets (Life Technologies, Carlsbad, CA). RNA isolated from cells was converted to cDNA using a High-Capacity RNA-to-cDNA kit (Life Technologies), which served as template in qPCR assays. Target gene expression was calculated using the ΔΔCT method, and b-actin served as the housekeeping gene.
Bacterial culture, FITC-labeling, and infection assays
Porphyromonas gingivalis strain 381 was cultured anaerobically on blood agar plates, and after 3-5 days, plate growth was used to seed brain-heart infusion broth supplemented with yeast extract, hemin, and menadione (Gibson & Genco, 2001) . After 24 h, bacteria were harvested by centrifugation, washed, adjusted to an optical density at 660 nm of 1 (1 9 10 9 colony forming units ml
À1
), and either placed in antibiotic-free complete RPMI-1640, or labeled with fluorescein isothiocyanate (FITC; 0.15 mg ml À1 ; Molecular Probes, Eugene, OR) under anaerobic conditions for 30 min (Pathirana et al., 2007) . Gram staining confirmed the purity of all bacterial cultures. Unlabeled, or FITC-labeled P. gingivalis were added to M1, M2, and M0 BMDMø at multiplicity of infection 100 in antibiotic-free RPMI-1640 medium for up to 24 h. For assays to define BMDMø immune response to P. gingivalis, bacteria were added to M1, M2, and M0 BMDMø for 24 h, at which time BMDMø viability was determined by Trypan blue staining, in addition, culture supernatant fluids were collected and stored frozen at À80°C until multiplex-based immunoassays were performed. The remaining BMDMø were washed, and surface molecule expression was assessed by flow cytometry. For binding and internalization assays, unbound bacteria were removed by washing, BMDMø were harvested, divided into two aliquots for flow cytometric measurement of mean fluorescence intensity of total bound bacteria, and to define internalized bacteria following Trypan blue quenching of extracellular FITC (Liang et al., 2009) .
Griess assay
In brief, the presence of total nitrite was measured in collected cell culture supernatant fluids by incubating individual 50-ll samples with 50-ll Griess reagent A and 50 ll Griess reagent B for 10 min in wells of 96-well plates, and absorbance at 540 nm for each sample was recorded. A standard curve using sodium nitrite was run in parallel with experimental samples, and was used to convert absorbance values to lM units.
Multiplex immunoassays
An 8-plex immunoassay kit (Invitrogen, Carlsbad, CA) was used to measure murine TNF-a, IL-1b, IL-6, IL-10, KC (CXCL1), monocyte chemotactic protein-1 (MCP-1; CCL2), macrophage inflammatory protein 1a (MIP-1a; CCL3), and regulated on activation normal T-cell expressed and secreted (RANTES; CCL5). Briefly, 50 ll samples were applied to the beads and the samples were manipulated following the manufacturer's instructions. Levels of each cytokine and chemokine were measured on a Luminex 100, and expressed as pg ml À1 determined from standards run in parallel with the test samples.
Flow cytometry
The BMDMø were washed, treated with Fc block (eBiosciences, San Diego, CA), then incubated with fluorescently labeled antibodies against mouse F4/80 (eBiosciences), MHCII (eBiosciences), Toll-like receptor 2 (TLR2; eBiosciences), TLR4 (eBiosciences), CD11b (MAC-1; BD Pharmingen, San Jose, CA), CD14 (eBiosciences), CD18 (BD Pharmingen), CD80 (Santa Cruz Biotechnology, Santa Cruz, CA), and CD86 (BD Pharmingen), or isotype control antibodies, per manufacturer's instructions. The cells were then fixed with 2% buffered paraformaldehyde, 10,000 gated events were collected for each sample and mean fluorescence intensity, and percentage of positive staining cells were determined.
Statistical analyses
All experiments were performed two or three times and data from individual experiments were combined, imported in PRISM statistical analysis software (Graphpad Software, La Jolla, CA), and the mean AE standard error of the mean for each group was determined. One-way analysis of variance and Tukey post-tests, or two-way analysis of variance with Bonferroni post-test were performed as indicated. A P value < 0.05 was considered significant.
RESULTS
Establishment of activated BMDMø subsets
Before defining the skewed BMDMø response to P. gingivalis, we confirmed that our cytokine treatments generated phenotypically distinct macrophage populations. Employing flow cytometry to measure surface expression of MHCII and CD86 we observed, as anticipated, that M1 BMDMø expressed the highest levels of these markers compared with either M0 or M2 skewed cells (Fig. 1A-H) . The RT-qPCR revealed that groups of BMDMø treated for 72 h with IFN-c + LPS or treated with IL-4 presented with high nos2 (M1 marker), or arg1 (M2 marker) gene expression, respectively. M0 expressed low levels of each gene (Fig. 1I ). Nitrite measurements revealed that only the M1 population of BMDMø expressed this marker (Fig. 1J) , whereas enzyme-linked immunosorbent assays supported that TNF-a ( Fig. 1K ) and IL-6 (Fig. 1L) were expressed by M1 BMDMø to a greater extent than either M0 or M2 BMDMø. Taken together, these data confirmed reproducible generation of M1 and M2 skewed BMDMø subsets.
M1 and M2 skewed BMDMø display different surface receptor profiles in response to P. gingivalis
It is known that macrophages display an array of surface receptors to P. gingivalis (Hajishengallis et al., 2006b) ; however, the influence of immunologic skewing before bacterial interaction in the evolution of surface receptor responses is essentially unknown. Before measuring expression of surface marker expression, we investigated whether immunologic skewing of BMDMø influenced cell viability after 24 h of culture with P. gingivalis. We observed that there were no significant changes in viability between subsets of BMDMø cultured with P. gingivalis (data not shown). Employing flow cytometry we observed that all BMDMø subsets cultured with P. gingivalis significantly increased F4/80 expression ( Fig. 2A) . Complement receptor (CR)3 is a b 2 -integrin heterodimer of CD11b and CD18 that plays an important role in host recognition of P. gingivalis (Hajishengallis et al., 2007) . We observed that M0 BMDMø responded to P. gingivalis with increased CD11b expression, whereas no effect on CD11b was observed with challenged M1 or M2 cells (Fig. 2B ). Challenge with P. gingivalis elicited increased CD18 expression on M0 BMDMø, whereas M1 and M2 skewed BMDMø responded with decreased CD18 staining, with M2 possessing greater reduction in CD18 staining than observed with M1 cells (Fig. 2C) . Toll-like receptors are pattern recognition receptors used by macrophages to recognize and process foreign material and participate in various aspects of the host response to P. gingivalis. TLR2 is linked to development of inflammatory responses, and oral bone loss to P. gingivalis (Yumoto et al., 2005; Burns et al., 2006; Ukai et al., 2008) . M0 and M2 BMDMø responded to P. gingivalis with significant increases in TLR2 expression, whereas M1 cells did not (Fig. 2D) . A slight increase in TLR4 expression by M0 cells cultured with P. gingivalis was observed compared with unchallenged BMDMø; however, this did not reach the level of significance (P > 0.05; Fig. 2E ). M2 BMDMø responded to P. gingivalis with a slight increase in TLR4 expression. Interestingly, M1 BMDMø responded to P. gingivalis challenge by significantly enhancing TLR4 expression (Fig. 2E) . CD14 is a co-receptor for TLRs (Hajishengallis et al., 2006a) . A profile of enhanced CD14 expression in response to P. gingivalis challenge was similar between all BMDMø subsets (Fig. 2F) .
Macrophages present antigen to T cells via MHCII and aided by co-receptor engagement including CD80 (B7-1), and CD86 (B7-2; Banchereau & Steinman, 1998; Underhill et al., 1999; Neefjes et al., 2011) . Therefore, we were interested in understanding if immunologically skewed macrophages responded to P. gingivalis challenge by modifying MHCII or co-receptor expression. Both M2 and M0 BMDMø responded to P. gingivalis challenge with a significant increase in MHCII (Fig. 3A) , whereas MHCII expression did not change in M1 cells (Fig. 3A) . In the M2 and M0 BMDMø populations, CD80 expression changed modestly following P. gingivalis challenge, whereas M1 BMDMø responded with a strong decrease in CD80 expression (Fig. 3B ). Exposure to P. gingivalis did not shift expression of CD86 in M0 BMDMø, whereas M1 responded to P. gingivalis challenge with a significant decrease in CD86 expression, and M2 cells increased CD86 expression following exposure (Fig. 3C ).
M1 and M2 skewing affects BMDMø cytokine and chemokine response to P. gingivalis As chronic inflammation is a hallmark of periodontal disease (Seymour & Gemmell, 2001; Pihlstrom et al., 2005; Silva et al., 2007) , we wanted to determine whether immunologically skewed BMDMø respond to P. gingivalis by producing different cytokine and chemokine profiles. Skewed and reference M0 BMDMø cultured with P. gingivalis possessed significantly higher levels of TNF-a and IL-6 than the unchallenged cells with TNF-a expression profiles M2 > M1 > M0, and IL-6 expression M2 > M0 > M1 (Fig. 4) . Little change in IL-1b production was observed between unchallenged and P. gingivalischallenged BMDMø (Fig. 4) . Challenge with P. gingivalis elicited IL-10 from all BMDMø with M0 > M1 > M2 (Fig. 4) , a profile that was the inverse of that observed for TNF-a. M2 and M0 responded to P. gingivalis with robust KC production M2 > M0, whereas M1 cells had little change in KC production Figure 1 Phenotypic description of M1 and M2 activated bone-marrow-derived macrophage (BMDMø) subsets before Porphyromonas gingivalis exposure. Bone marrow cells from C57BL-6 mice were cultured in macrophage colony-stimulating factor for 7 days, harvested, and cultured with fresh medium (M0; control), recombinant murine interferon-c (IFN-c; 100 U ml À1 ) + ultrapure Escherichia coli lipopolysaccharide (LPS) 0111:B4 (10 ng ml À1 ; M1), or recombinant murine interleukin-4 (IL-4; 20 U ml À1 ; M2). Flow cytometry was used to measure surface expression of MHCII. (A-C) Representative histograms where bold trace is specific staining and shaded trace is isotype control, (D) Mean fluorescence intensity (MFI; n = 6 AE SEM for each), and CD86 (E-G) representative histograms where bold trace is specific staining and shaded trace is isotype control, (H) MFI, n = 6 AE SEM for each; RT-qPCR was used to define nos2 and arg1 gene expression by macrophage subsets normalized to b-actin (I), n = 2 AE SEM for each; culture supernatant fluid levels of nitrite (lM; J), tumor necrosis factor-a (TNFa; pg ml À1 ; K), and IL-6 (pg ml À1 ; L) expressed by polarized macrophages (n = 6 AE SEM for each).
relative to unchallenged BMDMø (Fig. 4) . Profiles of MCP-1 and RANTES were similar to that observed for KC (Fig. 4) , although no difference in MCP-1 was observed between M0 and M1 cells cultured with P. gingivalis. MIP-1a production in response to P. gingivalis challenge was different between macrophage subsets with M2 > M1 > M0 (Fig. 4) .
M2 macrophages bind P. gingivalis more robustly than M1 macrophages
As macrophages play key roles in handling bacterial pathogens (Boisvert et al., 2014) , and P. gingivalis adheres to, and is internalized within, macrophages (Liang et al., 2009) , we investigated whether skewed macrophages differ in their capacity to bind and internalize P. gingivalis. Flow cytometry revealed that BMDMø subsets bound FITC-P. gingivalis in a time dependent manner (Fig. 5A ). M2 cells bound P. gingivalis more robustly than M1 cells, and M0 BMDMø bound P. gingivalis least robustly. To determine whether skewing influenced the capacity of BMDMø to internalize P. gingivalis, FITC-P. gingivalis-infected BMDMø subsets were treated with trypan blue to quench extracellular FITC (Liang et al., 2009) . All cultures treated with trypan blue showed a decrease in detectable fluorescence compared with untreated aliquots. M1 and M2 cells possessed similarly enhanced levels of internalized P. gingivalis compared with M0 ( Fig. 5B) , suggesting that the numbers of P. gingivalis internalized by phenotypically distinct BMDMø were similar.
DISCUSSION
Despite the development of robust immune responses, the host is unable to resolve periodontal infections and disease progression. The reasons for this are unclear; however, several factors including microbial dysbiosis, immune dysfunction, and apparent failure of antibodies to clear key organisms likely contribute (Lamster et al., 1990; Nakagawa et al., 1990; Darveau et al., 2012; Wang, 2015) . Macrophages comprise an important fraction of the total inflammatory cell population present in periodontal disease lesions (Okada & Murakami, 1998) ; however, their role in disease particularly in the context of responsiveness to immunologic cues guiding cell function before pathogen interaction is poorly understood. Recently it was reported that injection of naive animals with P. gingivalis drives recruitment of differing sets of macrophages, including M1 and M2 cell populations, with M1 > M2 (Lam et al., 2014) , and are broadly in agreement with the clinical environment in periodontitis, which possesses molecules favorable for simultaneous M1 and M2 macrophage skewing (Navarrete et al., 2014) . Hence, macrophage skewing as a consequence of the environment encountered by infiltrating cells during periodontal disease before bacterial exposure is a poorly defined attribute that probably plays an important, and functionally relevant, role in host recognition and subsequent immune response of these cells to P. gingivalis challenge.
Toll-like receptors, and in particular TLR2, are implicated in the host response to P. gingivalis (Hajishengallis et al., 2006b; Gibson & Genco, 2007; Costalonga et al., 2009; Burns et al., 2010) . BMDMø respond to P. gingivalis with enhanced TLR2 (Zhou & Amar, 2007; Liang et al., 2009 ), yet little change in TLR4 expression (Liang et al., 2009) . Unexpectedly, we observed that macrophages skewed in M1 orientation before P. gingivalis challenge failed to change TLR2 expression; however, TLR4 expression was augmented on both M1 and M2 skewed macrophages. This finding suggested that skewed macrophages adapt different pattern recognition receptor repertoires in response to P. gingivalis than observed by naive macrophages typically used to study cell response to challenge, and that microenvironments favoring M1 skewing switch macrophages from a predominating TLR2, to a predominating TLR4, response. Our findings build on those of Burns et al. (2006) regarding TLR4, where wild-type and TLR4 À/À mice, but not TLR2 À/À mice, developed a potent cytokine response to P. gingivalis. Indeed, we observed that M1 skewed BMDMø do not produce a cytokine and chemokine response to P. gingivalis that is as robust as M2 activated cells, and M2 cells bind P. gingivalis more robustly than M1 cells. CD14, a co-receptor for TLR4 that is important in recognition of bacterial LPS (Fenton & Golenbock, 1998) , expression was significantly increased in all macrophage populations in response to P. gingivalis challenge, suggesting that other elements of TLR4 sensing of bacterial LPS were not affected. Porphyromonas gingivalis signaling via TLR2 induces conformational changes in CR3 (a heterodimer of CD11b and CD18) to a high-affinity receptor, that is important for attachment and internal survival of P. gingivalis in macrophages (Hajishengallis, 2011) . We observed that immunologic activation of macrophages before P. gingivalis infection led to a similar and modest baseline reduction in CD11b compared with M0 cells; however, in response to P. gingivalis exposure, only M0 cells responded with increased CD11b. Interestingly, both M1 and M2 BMDMø responded to P. gingivalis challenge with reduced CD18 expression. One explanation for the observed reduction in CD18 by skewed macrophage to P. gingivalis reflects its use in attachment/internalization of P. gingivalis (such as through CR3); however, the absence of change in CD11b does not fully substantiate attachment-mediated use Figure 3 MHCII, CD80 and CD86 surface expression by skewed bone-marrow-derived macrophages (BMDMø) to Porphyromonas gingivalis. Control M0 and skewed M1, and M2 BMDMø were cultured in medium alone (open bars) or with P. gingivalis 381 MOI 100 (filled bars) for 24 h and the mean fluorescence intensity (MFI) expression of (A) MHCII, (B) CD80, and (C) CD86 was determined by flow cytometry. Bars represent mean AE SEM; n = 6 mice per group; ***P < 0.001 by two-way analysis of variance with Bonferroni post test.
of CD18 via intact CD3. Our data point to possible use of multiple receptors by macrophages to interact with P. gingivalis. As macrophages participate in antigen presentation to T cells to engage adaptive immunity (Unanue, 1984; Hume, 2008) , and the host is unable to resolve periodontal disease, the immunologic environment encountered by macrophages before infection may critically influence expression of key receptors in this process (Balbo et al., 2001) . Enhanced MHCII expression was observed on M0 and M2 cells challenged with P. gingivalis, whereas MHCII levels did not change on M1 cells, suggesting that immunologic skewing may impact key elements of macrophage capacity to properly present antigen. These findings extend knowledge of macrophage types encountered in the oral cavity where two distinct populations based on MHCII and inducible nitric oxide synthase (iNOS) expression were observed to co-exist, MHCII À iNOS + , and MHCII + iNOS À (Suzuki et al., 1999 requires co-stimulatory molecule engagement; interestingly we observed strong P. gingivalis-dependent reduction in the expression of CD80 and CD86 by M1 macrophages. M2 cells did not shift expression of CD80 in response to P. gingivalis challenge, these cells responded with robust increase in CD86. In culture, naive non-skewed macrophages that encounter P. gingivalis LPS or its fimbriae express MHCII and CD80 (Cohen et al., 2004; Hajishengallis et al., 2004) . CD80 and CD86 expression has been reported on macrophages in clinical samples, but levels did not reflect clinical status (Gemmell et al., 2001b) . Employing mice deficient in CD80 or CD86 and P. gingivalis HagB protein, Zhang et al. (2004) revealed important roles for CD86 (B7-2) in antibody production, and cytokine response to P. gingivalis. Our observed reduction in co-stimulatory molecule expression by M1 cells, when compared with the findings of Zhang et al. (2004) suggest that immunologic skewing to M1 before P. gingivalis exposure may impair the development of a properly coordinated innate immune response to P. gingivalis, thus dysregulating integration of T-cell help during P. gingivalis infection, and may impact downstream coordination of host antibody production. The periodontium during periodontal disease presents with a dynamic immune response (Gemmell et al., 2007) , so it is plausible that local shifts in inflammatory mediator expression during disease contribute to progression of periodontitis (Ellis et al., 1998) . We observed an unexpected overall profile where M2 cells generated a more robust response to P. gingivalis challenge than either M1 or M0 cells. The notable exception was IL-10, which was secreted most robustly by reference M0 cells followed by M1, then M2 cells. Interleukin-10 is detected at high levels in periodontal disease (Lappin et al., 2001) , and has been linked to oral bone loss (Sasaki et al., 2004) . The profile of IL-10 production to P. gingivalis was opposite to that observed for TNF-a, which was produced in greater abundance in M2 BMDMø than M1 or M0 cells. This was unanticipated as M2 cells are associated with higher IL-10 production than M1 cells (Weisser et al., 2013) , wound healing, and are considered not inflammatory (Sica & Mantovani, 2012) . Although differences in data could reflect differences in systems employed, we speculate that this profile reflects a cellular response to pathogen encountered at a site where infection is not anticipated by the host, such as a site of wound healing. To this point, our observations into chemokine production by immunologically skewed macrophages reflected an overall enhanced responsivity of M2 over that of M1 macrophages.
We generated M1 cells using a cocktail of IFN-c with enteric LPS. Hence the reduced response of M1 BMDMø compared with M2 cells at several points may suggest an anergic profile (Foey & Crean, 2013) . In our hands, anergy as a consequence of our macrophage activation approach is not supported as we observed that P. gingivalis elicited more TNF-a and MIP-1a in activated BMDMø than from non-activated macrophages. Furthermore, we previously reported that E. coli LPS treatment of macrophages before P. gingivalis exposure did not lead to tolerization, rather partial sensitization of these cells to subsequent P. gingivalis exposure was observed (Papadopoulos et al., 2013) . Our results agree and extend from recent findings regarding reduction in chemokine production from M1 skewed macrophages to P. gingivalis challenge (Huang et al., 2016) . On the contrary, a recent study investigating skewed macrophage immune responses to P. gingivalis LPS suggested a less robust response from M2 macrophages than M1 cells (Holden et al., 2014) . We do not understand why our data differ from this study in that we observed differences between activation types and cytokine, chemokine, and cell molecule expression; however, the reported differences may reflect systems employed, as we used live P. gingivalis to define macrophage response to live intact bacteria, rather than a purified ligand.
Our findings identify that the inflammatory milieu encountered by macrophages before pathogen interaction dysregulates the responsivity of these cells to P. gingivalis challenge and the observed phenotypes may impact significantly in initiation, progression, and complexity of inflammation observed in periodontal disease. Based on the complex inflammatory milieu described in human periodontitis, it is plausible that both M1 and M2 macrophage subsets exist in periodontal lesions and so would be in position to respond to bacterial infection or microbial insult simultaneously. Alternatively, there may be tissue-level microenvironments in periodontal lesions that could favor M1 and M2 subset activation. Suzuki et al. (1999) employed a histologic approach to demonstrate the presence of different macrophage types in rat periapical lesion tissue, thus supporting the notion that phenotypically distinct macrophages may exist in periodontal lesions. In the context of atherosclerosis, the presence of phenotypically distinct macrophages in diseased vascular tissue has been identified, and there is a degree of spatial partitioning of these phenotypic subsets in these compartments (Chinetti-Gbaguidi et al., 2011) . Future investigations are needed to define the relative numbers and phenotypic characteristics of the macrophage cell infiltrate in periodontal tissues, as well as to determine the spatial and functional distribution of macrophage subsets within tissues obtained from individuals with periodontal disease.
